ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Nephrology

Top Nephrology Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHRISTINA TURNER MD

Nephrology

1,446

$570K

162
123 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 31%

$394
Average prescription price

Avg: $135

MOHAMED ATTA M.D.

Nephrology

837

$282K

53
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 31%

$337
Average prescription price

Avg: $135

RADCLIFFE M THOMAS MD PA

Nephrology

181

$58.4K

14
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

82%
prescriptions for brand name drugs

Avg: 31%

$323
Average prescription price

Avg: $135

IRA MANDELL M.D.

Nephrology

801

$231K

116
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 31%

$288
Average prescription price

Avg: $135

PING-HSIN CHEN M.D.

Nephrology

922

$259K

104
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 31%

$281
Average prescription price

Avg: $135

ANITA PASUMARTHY M.D.

Nephrology

844

$232K

120
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 31%

$275
Average prescription price

Avg: $135

MELANIE HAROUN M.D.

Nephrology

322

$87.1K

22
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 31%

$270
Average prescription price

Avg: $135

JEFFREY POSNER M.D.

Nephrology

956

$255K

151
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 31%

$267
Average prescription price

Avg: $135

JASWINDER SIDHU M.D.

Nephrology

474

$125K

64
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 31%

$264
Average prescription price

Avg: $135

IBIKUNLE KOYA MD

Nephrology

828

$212K

77
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 31%

$256
Average prescription price

Avg: $135

GERARD LOWDER M.D.

Nephrology

1,175

$298K

94
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 31%

$254
Average prescription price

Avg: $135

SAEED KRONFLI M.D.

Nephrology

1,147

$285K

143
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 31%

$248
Average prescription price

Avg: $135

AJAY KUMAR M.D.

Nephrology

768

$189K

140
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 31%

$246
Average prescription price

Avg: $135

SANJEEB MISHRA M.D.

Nephrology

1,494

$365K

147
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 31%

$245
Average prescription price

Avg: $135

ROHAN RENGEN D.O.

Nephrology

1,354

$319K

139
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 31%

$236
Average prescription price

Avg: $135

DUVURU GEETHA M.D.

Nephrology

1,299

$303K

67
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 31%

$233
Average prescription price

Avg: $135

JOEL LAHN M.D.

Nephrology

1,034

$237K

96
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 31%

$229
Average prescription price

Avg: $135

NIRMALA YADLA MD

Nephrology

696

$159K

75
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 31%

$229
Average prescription price

Avg: $135

JONATHAN RUDICK MD

Nephrology

879

$197K

94
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 31%

$225
Average prescription price

Avg: $135

NAVNEET AHUJA M.D.

Nephrology

936

$207K

118
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 31%

$221
Average prescription price

Avg: $135

AKSHAY AMIN MD

Nephrology

1,622

$355K

139
68 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 31%

$219
Average prescription price

Avg: $135

JENNIFER ERAS M.D.

Nephrology

862

$186K

101
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 31%

$215
Average prescription price

Avg: $135

GAIL SEIKEN M.D.

Nephrology

813

$175K

77
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 31%

$215
Average prescription price

Avg: $135

TAMIL KUPPUSAMY M.D.

Nephrology

1,170

$251K

114
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 31%

$215
Average prescription price

Avg: $135

SUMESKA THAVARAJAH M.D.

Nephrology

1,424

$303K

95
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 31%

$213
Average prescription price

Avg: $135

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank